Simmunome secures $2 million to make clinical trials more efficient with AI
Using artificial intelligence, Montréal-based Simmunome aims to help predict whether drug candidates will succeed or fail in clinical trials.
Source: betakit.com
Stay updated with breaking news from Altis Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Using artificial intelligence, Montréal-based Simmunome aims to help predict whether drug candidates will succeed or fail in clinical trials.
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.
Plus: A new Canadian generative image startup gets $22.3 million.
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.
New funding will help Canadian organizations developing super-fast computers.